Maoz, Myriam <br/><br/>
Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes.  [electronic resource] 

 -  Scientific reports  12 2019 
 - 18795 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-019-55455-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Disease Progression<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Gene Amplification<br/>Genes, erbB-2<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--classification<br/>Polymerase Chain Reaction<br/>Protein Phosphatase 2C--antagonists & inhibitors<br/>Receptor, ErbB-2--genetics<br/>Whole Genome Sequencing<br/>Young Adult